Galectin Therapeutics Statistics
Total Valuation
GALT has a market cap or net worth of $79.61 million. The enterprise value is $154.61 million.
Important Dates
The last earnings date was Monday, March 31, 2025, before market open.
Earnings Date | Mar 31, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
GALT has 63.18 million shares outstanding. The number of shares has increased by 3.57% in one year.
Current Share Class | 62.76M |
Shares Outstanding | 63.18M |
Shares Change (YoY) | +3.57% |
Shares Change (QoQ) | +0.75% |
Owned by Insiders (%) | 20.26% |
Owned by Institutions (%) | 16.03% |
Float | 43.97M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | -0.83 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -7.66 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | -224.08% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$3.37M |
Employee Count | 14 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.33% in the last 52 weeks. The beta is 0.69, so GALT's price volatility has been lower than the market average.
Beta (5Y) | 0.69 |
52-Week Price Change | -48.33% |
50-Day Moving Average | 1.45 |
200-Day Moving Average | 2.11 |
Relative Strength Index (RSI) | 35.26 |
Average Volume (20 Days) | 263,581 |
Short Selling Information
The latest short interest is 8.15 million, so 12.91% of the outstanding shares have been sold short.
Short Interest | 8.15M |
Short Previous Month | 8.12M |
Short % of Shares Out | 12.91% |
Short % of Float | 18.55% |
Short Ratio (days to cover) | 33.49 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -42.43M |
Pretax Income | -44.65M |
Net Income | -47.20M |
EBITDA | n/a |
EBIT | -42.43M |
Earnings Per Share (EPS) | -$0.76 |
Full Income Statement Balance Sheet
The company has $27.06 million in cash and $104.59 million in debt, giving a net cash position of -$77.53 million or -$1.23 per share.
Cash & Cash Equivalents | 27.06M |
Total Debt | 104.59M |
Net Cash | -77.53M |
Net Cash Per Share | -$1.23 |
Equity (Book Value) | -92.48M |
Book Value Per Share | -1.52 |
Working Capital | n/a |
Full Balance Sheet Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |